Grifols Sells $1.1B for Acquisition -
January 13, 2011
Spanish pharmaceutical company Grifols priced $1.1 billion on the U.S. junk bond market...
The full article is available to Private Placement Letter subscribers only
Already a print subscriber? As a print subscriber, you are entitled to online access. Please click here to activate your account.

